Results 161 to 170 of about 2,227,240 (299)

Performance Characteristics of Anti‐Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

open access: yesArthritis Care &Research, Accepted Article.
Background Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti‐collagen II (anti‐Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick   +6 more
wiley   +1 more source

Incidence of surgical site infections in cerebrovascular surgery: systemic risk factors. [PDF]

open access: yesBrain Spine
Messino V   +4 more
europepmc   +1 more source

OP0122 Venous thromboembolism in systemic sclerosis: prevalence, risk factors and impact on survival [PDF]

open access: bronze, 2017
SR Johnson   +3 more
openalex   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

open access: yesArthritis Care &Research, Accepted Article.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner   +14 more
wiley   +1 more source

Multi-systemic risk of post-acute sequelae associated with SARS-CoV-2 reinfection. [PDF]

open access: yesBMC Glob Public Health
Lim JT   +7 more
europepmc   +1 more source

Systemic risk-sharing framework of cryptocurrencies in the COVID-19 crisis. [PDF]

open access: yesFinanc Res Lett, 2022
Akhtaruzzaman M   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy